Insider Transactions in Q2 2023 at Cyclo Therapeutics, Inc. (CYTH)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Ce Rick Strattan Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,360
+8.82%
|
-
|
|
May 17
2023
|
William S Shanahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,971
+22.46%
|
-
|
|
May 17
2023
|
Francis Patrick Ostronic Director |
BUY
Grant, award, or other acquisition
|
Direct |
26,700
+9.68%
|
-
|
|
May 17
2023
|
Randall M. Toig Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,059
+22.42%
|
-
|
|
May 17
2023
|
Markus Sieger Director |
BUY
Grant, award, or other acquisition
|
Direct |
42,962
+17.4%
|
-
|
|
Apr 20
2023
|
Jeffrey Tate Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
29,941
+32.53%
|
$0
$0.71 P/Share
|
|
Apr 20
2023
|
Francis Patrick Ostronic Director |
BUY
Open market or private purchase
|
Direct |
59,881
+21.22%
|
$0
$0.71 P/Share
|
|
Apr 20
2023
|
Markus Sieger Director |
BUY
Open market or private purchase
|
Direct |
59,881
+27.1%
|
$0
$0.71 P/Share
|
|
Apr 20
2023
|
N Scott Fine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
299,402
+40.25%
|
$0
$0.71 P/Share
|